Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tryptamine Therapeutics ( (AU:TYP) ) has issued an update.
Tryptamine Therapeutics Limited has issued 165,588,237 fully paid ordinary shares at a price of $0.034 per share, as part of a secondary trading notice in compliance with the Corporations Act 2001. This move is expected to impact the company’s market operations by potentially increasing liquidity and investor interest, as the company confirms compliance with relevant legal provisions and the absence of any excluded information.
More about Tryptamine Therapeutics
Tryptamine Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and distribution of therapeutic products. The company is listed on the Australian Securities Exchange (ASX) under the ticker TYP.
Average Trading Volume: 2,495,811
Technical Sentiment Signal: Buy
Current Market Cap: A$51.98M
See more data about TYP stock on TipRanks’ Stock Analysis page.